Generex Biotechnology Corporation
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Generex Biotechnology Corporation
In light of the Russia-Ukraine conflict, Scrip looks at data to gauge if manufacturing partners for COVID-19 vaccine Sputnik V or Light, in India, China and Korea could be left holding unsold inventory earmarked for exports
When a small biotech company acquires a failed drug from big pharma and plans to repeat the clinical studies expecting a positive result, is that not a definition of insanity?
German firm’s antibody-drug conjugates use amanitin payload. Plus deals involving Sanwa Kagaku/Crinetics, Takeda/Code Bio, Taro/Alchemee, Mankind/Dr. Reddy’s and more.
Public Company Edition: As their stock prices plummet, Adagio reshuffles its research plan and names a new CEO, while Yumanity restructures and seeks strategic alternatives. Also, Bristol sells $6bn worth of notes, Amgen issues $750m green bond, and Inhibrx and Amryt amend and refinance debt.
- Medical Devices
- Large Molecule
- Other Names / Subsidiaries
- Antigen Express, Inc.
- Grainland Pharmacy LLC
- Hema Diagnostic Systems, LLC
- Medisource Partners
- NuGenerex Distribution Solutions, LLC
- NuGenerex Immuno-Oncology
- Pantheon Medical
- Pantheon Medical – Foot & Ankle
- Regentys Corporation
- Veneto Holdings, LLC